Dermatology has long been one of medicine's worst offenders for patient wait times — and it's getting worse. A 2025 AMN Healthcare survey found patients wait an average of 36.5 days to see a dermatologist, a figure that's jumped 50% since 2004. To tackle this, the University of Pennsylvania Health System rolled out an acuity-driven, decision tree-based scheduling model across all its ambulatory dermatology clinics — and the results are turning heads.

The system works by having call center schedulers ask patients targeted questions (e.g., personal or family history of skin cancer, presence of a growing lesion) to slot them into acute (within 7 days), subacute (within 21 days), or routine (within 90 days) appointment blocks. Unused slots automatically open up two days before the appointment, maximizing efficiency without sacrificing access for existing patients.

By the Numbers:

• 76.8% reduction in lead times for new patient visits
• 63.9% reduction for new patient visits resulting in a biopsy
• 70.8% reduction for biopsy-proven malignancies
• No-show rates dropped from 18.6% to 8.1%
• Penn's system handles 40,000–50,000 new patient inquiries per year but only has 20,000–30,000 slots available

Why it matters: Delayed dermatology care isn't just inconvenient — it can be deadly. Melanoma patients treated more than 3 months after diagnosis face significantly higher mortality. This model offers a practical, low-tech blueprint that any health system could adopt to prioritize the sickest patients and reduce costly no-shows.